APA (7th ed.) Citation

S, Z., C, S., ZB, S., J, H., & JP, Y. (2026). Outcomes and Safety of PD-1 Blockades Plus Anlotinib Regimen in Previously-Treated Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective, Exploratory Study. Drug design, development and therapy, 20, 587621. https://doi.org/10.2147/DDDT.S587621

Chicago Style (17th ed.) Citation

S, Zhang, Su C, Shen ZB, Huo J, and Yang JP. "Outcomes and Safety of PD-1 Blockades Plus Anlotinib Regimen in Previously-Treated Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective, Exploratory Study." Drug Design, Development and Therapy 20 (2026): 587621. https://doi.org/10.2147/DDDT.S587621.

MLA (9th ed.) Citation

S, Zhang, et al. "Outcomes and Safety of PD-1 Blockades Plus Anlotinib Regimen in Previously-Treated Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective, Exploratory Study." Drug Design, Development and Therapy, vol. 20, 2026, p. 587621, https://doi.org/10.2147/DDDT.S587621.